Skip to Content
Maxiplus
About Maxiplus
About Maxiplus
Global Network
Company Culture
History
Ethics
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics/Medicals
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Annual Reports
Stock Info
IR
CEO
EN
View all menu
About Maxiplus
About Maxiplus
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Rating
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics/Medicals
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events
IR Letter
Earnings announcement
Analysis Data
FAQ
Maxiplus
Global Healthcare Group
The Best Partner for You
IR
IR information of MAXIPLUS MEDICAL & PHARMACEUTICAL
Events
IR Letter
Earnings announcement
Analysis Data
IR Letter
IR Letter 목록
No.
Title
Attachments
Registration Date
1
Nuceiva™(Botulinum toxin product) Approval in Europe
File Download
2020-03-09
1
Search
search word
Delete
Search